These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7926260)

  • 41. Distinguishing androgen receptor agonists and antagonists: distinct mechanisms of activation by medroxyprogesterone acetate and dihydrotestosterone.
    Kemppainen JA; Langley E; Wong CI; Bobseine K; Kelce WR; Wilson EM
    Mol Endocrinol; 1999 Mar; 13(3):440-54. PubMed ID: 10077001
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quantifying effects of ligands on androgen receptor nuclear translocation, intranuclear dynamics, and solubility.
    Marcelli M; Stenoien DL; Szafran AT; Simeoni S; Agoulnik IU; Weigel NL; Moran T; Mikic I; Price JH; Mancini MA
    J Cell Biochem; 2006 Jul; 98(4):770-88. PubMed ID: 16440331
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ligand-specific dynamics of the androgen receptor at its response element in living cells.
    Klokk TI; Kurys P; Elbi C; Nagaich AK; Hendarwanto A; Slagsvold T; Chang CY; Hager GL; Saatcioglu F
    Mol Cell Biol; 2007 Mar; 27(5):1823-43. PubMed ID: 17189428
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structural basis for antagonism and resistance of bicalutamide in prostate cancer.
    Bohl CE; Gao W; Miller DD; Bell CE; Dalton JT
    Proc Natl Acad Sci U S A; 2005 Apr; 102(17):6201-6. PubMed ID: 15833816
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In Silico and In Vitro Investigation of the Piperine's Male Contraceptive Effect: Docking and Molecular Dynamics Simulation Studies in Androgen-Binding Protein and Androgen Receptor.
    Chinta G; Ramya Chandar Charles M; Klopčič I; Sollner Dolenc M; Periyasamy L; Selvaraj Coumar M
    Planta Med; 2015 Jul; 81(10):804-12. PubMed ID: 26039262
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A novel androgen receptor mutant, A748T, exhibits hormone concentration-dependent defects in nuclear accumulation and activity despite normal hormone-binding affinity.
    James AJ; Agoulnik IU; Harris JM; Buchanan G; Tilley WD; Marcelli M; Lamb DJ; Weigel NL
    Mol Endocrinol; 2002 Dec; 16(12):2692-705. PubMed ID: 12456791
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antiandrogen bicalutamide promotes tumor growth in a novel androgen-dependent prostate cancer xenograft model derived from a bicalutamide-treated patient.
    Yoshida T; Kinoshita H; Segawa T; Nakamura E; Inoue T; Shimizu Y; Kamoto T; Ogawa O
    Cancer Res; 2005 Nov; 65(21):9611-6. PubMed ID: 16266977
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 5 alpha-Dihydrotestosterone-induced uteroglobin synthesis in rabbit uterus is not inhibited by antiandrogen administration but is prevented by estradiol.
    Kopu H
    Biochim Biophys Acta; 1981 Jul; 654(2):293-6. PubMed ID: 7284383
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Androgen receptor is targeted to distinct subcellular compartments in response to different therapeutic antiandrogens.
    Whitaker HC; Hanrahan S; Totty N; Gamble SC; Waxman J; Cato AC; Hurst HC; Bevan CL
    Clin Cancer Res; 2004 Nov; 10(21):7392-401. PubMed ID: 15534116
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Isolation and characterization of the androgen receptor mutants with divergent transcriptional activity in response to hydroxyflutamide.
    Wang C; Young WJ; Chang C
    Endocrine; 2000 Feb; 12(1):69-76. PubMed ID: 10855693
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antiandrogen gold nanoparticles dual-target and overcome treatment resistance in hormone-insensitive prostate cancer cells.
    Dreaden EC; Gryder BE; Austin LA; Tene Defo BA; Hayden SC; Pi M; Quarles LD; Oyelere AK; El-Sayed MA
    Bioconjug Chem; 2012 Aug; 23(8):1507-12. PubMed ID: 22768914
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A stable prostatic bioluminescent cell line to investigate androgen and antiandrogen effects.
    Térouanne B; Tahiri B; Georget V; Belon C; Poujol N; Avances C; Orio F; Balaguer P; Sultan C
    Mol Cell Endocrinol; 2000 Feb; 160(1-2):39-49. PubMed ID: 10715537
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rational design and synthesis of androgen receptor-targeted nonsteroidal anti-androgen ligands for the tumor-specific delivery of a doxorubicin-formaldehyde conjugate.
    Cogan PS; Koch TH
    J Med Chem; 2003 Nov; 46(24):5258-70. PubMed ID: 14613328
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human prostatic cell line PNT1A, a useful tool for studying androgen receptor transcriptional activity and its differential subnuclear localization in the presence of androgens and antiandrogens.
    Avancès C; Georget V; Térouanne B; Orio F; Cussenot O; Mottet N; Costa P; Sultan C
    Mol Cell Endocrinol; 2001 Nov; 184(1-2):13-24. PubMed ID: 11694337
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phosphorylation/dephosphorylation of androgen receptor as a determinant of androgen agonistic or antagonistic activity.
    Wang LG; Liu XM; Kreis W; Budman DR
    Biochem Biophys Res Commun; 1999 May; 259(1):21-8. PubMed ID: 10334909
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Two androgen response elements in the androgen receptor coding region are required for cell-specific up-regulation of receptor messenger RNA.
    Dai JL; Burnstein KL
    Mol Endocrinol; 1996 Dec; 10(12):1582-94. PubMed ID: 8961268
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of steroidal and non-steroidal antiandrogens on the androgen binding properties of the rat ventral prostate androgen receptor.
    Steinsapir J; Mora G; Muldoon TG
    Biochim Biophys Acta; 1991 Aug; 1094(1):103-12. PubMed ID: 1883848
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Trypsin digestion of the inositol trisphosphate receptor: implications for the conformation and domain organization of the protein.
    Joseph SK; Pierson S; Samanta S
    Biochem J; 1995 May; 307 ( Pt 3)(Pt 3):859-65. PubMed ID: 7741718
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 3 beta-acetoxyandrost-1,5-diene-17-ethylene ketal functions as a potent antiandrogen with marginal agonist activity.
    Miyamoto H; Marwah P; Marwah A; Lardy H; Chang C
    Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4440-4. PubMed ID: 12672951
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Functional analysis of androgen receptor N-terminal and ligand binding domain interacting coregulators in prostate cancer.
    Yeh S; Sampson ER; Lee DK; Kim E; Hsu CL; Chen YL; Chang HC; Altuwaijri S; Huang KE; Chang C
    J Formos Med Assoc; 2000 Dec; 99(12):885-94. PubMed ID: 11155740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.